Home
Centre for Cancer Biomarkers CCBIO

News archive for Centre for Cancer Biomarkers CCBIO

In collaboration with the Vascular Biology Program (VBP), Boston Children’s Hospital, CCBIO recently completed the second CCBIO INTPART long course CCBIO907. This year, the course was given in digital format, and it was well visited by local students and researchers, participants from other institutions all over Norway, and also from Finland, Sweden and Denmark, in addition to some from other... Read more
CCBIO Postdoc Katrin Kleinmanns, together with CCBIO PhD Katharina Bischoff and Researcher Vibeke Fosse, recently published 2 articles in EBioMedicine. Their work describing CD24-targeted near-infrared (NIR) fluorescence imaging in patient-derived xenograft (PDX) models of high-grade serous ovarian carcinoma (HGSOC), confirms an improvement of cytoreduction of ovarian cancer in PDX orthotopic... Read more
The pandemic situation and lockdown of campus has forced CCBIO to think new in order to fulfill the goals for the CCBIO Research School for Cancer Studies. On fairly short notice, the 2 planned spring courses were rescheduled to new dates and organized through digital platforms. Despite of limited time to get the word out, registration for both courses soon had to be closed, due to great interest... Read more
The CCBIO International Faculty was established to support the Centre through active collaborations and strategic advice. In addition to the 13 already affiliated members, we have now recruited a new member, Marta Bertolaso from Rome, Italy, and have the pleasure of presenting her and her unique contribution to CCBIO.
CCBIO applied for and recently received continued support from the Research Council of Norway (RCN) and the Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education (DIKU) for phase 2 of the INTPART project: “Bergen-Harvard Cancer Studies phase 2: Continued Partnership for Responsible Education, Research and Innovation Excellence.”
CCBIO operates within the health services in addition to the Faculty of Medicine at the UiB and is subject to the guidelines issued by both institutions (see below links). As a consequence, we are reducing our activities accordingly. Please check the calendar for details. Notably, the CCBIO Annual Symposium and the Satellite Symposium have been cancelled.
CCBIO recently completed its CCBIO903 course Cancer Research: Ethical, Economic and Social Aspects, including a CCBIO Special Seminar, titled “Cancer in the news”. The course is quite unique on a global basis, and recruited participants with a great variety of backgrounds and of geographical locations, such as Bergen (CCBIO), Oslo (Oslo University Hospital, Institute for Cancer Research), London... Read more
Professor Hani Gabra was recently appointed Chief Medical Officer at BerGenBio, based in Oxford UK. Professor Gabra has been part of CCBIO's network of international affiliated researchers since 2016, and considers his affiliation to CCBIO both an advantage and a prerequisite for his role as CMO for BerGenBio. He also finds there are clear opportunities for increased interaction between... Read more
Since CCBIO was established five years ago, 17 students in the Medical Student Research Program have been affiliated to the center's research groups, and several have proceeded to a PhD degree. The students in the program are genuinely interested and dedicated, but also lacking research experience and in need of close follow-up and mentoring. Nevertheless, CCBIO has very good experiences in... Read more
In 2016 CCBIO’s Associate Investigator Professor Daniela Elena Costea received 3 million NOK in funding from the Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education (https://diku.no/en) for a 3 year collaboration project for education and research in oral pathology and oral cancer between Norway, Moldova, Belarus and Armenia. Due to its achievements, the... Read more
CCBIO Associate Researcher Agnete S.T. Engelsen has just completed a one-year certificate program, with distinction, at Harvard Medical School (HMS), the High-Impact Cancer Research (HICR): Cancer, Biology and Therapeutics Program. Engelsen was the first attendee from Norway in this diverse group of highly motivated new and seasoned researchers from 42 countries, all around the world.
CCBIO hosted the 4th Annual Scandinavian Seminar on Translational Pathology at Solstrand Hotel, Os (Bergen), with 78 dedicated participants from Norway, Sweden and Finland.
October 15th, Professor Bruce R. Zetter from Harvard Medical School and Boston Children’s Hospital was appointed as Honorary Doctor at the University of Bergen, Faculty of Medicine. The day before, October 14th, he gave his honorary doctor lecture, on the topic "RNA as a tool for cancer therapy".
Det medisinske fakultets nye æresdoktor Bruce R. Zetter sier at utnevnelsen vil føre til et enda sterkere bånd mellom Harvard Medical School og Universitetet i Bergen.
Iceland’s dramatic landscape served as backdrop for generating ideas and action plans for new collaborations between the University of Bergen/CCBIO and Harvard Medical School/Vascular Biology Program in a meeting August 29th to September 3rd.
The University of Bergen is appointing 10 new Honorary Doctors, one of which is Harvard Professor Bruce Zetter, very well known to the CCBIO family, both as advisor in the CCBIO Scientific Advisory Board, and through the CCBIO-VBP INTPART collaboration.
The collaboration project for education and research in oral pathology between Norway, Moldova, Belarus and Armenia is an important internationalization project financed by DIKU through the Eurasia program. Within this project, UiB/CCBIO is currently hosting a master student, Olga Golburean, a graduated dental hygienist who is taking her master degree in global health with Professor Dana Costea... Read more

Pages